Conaghan PG, Bowes MA, Kingsbury SR, et al. Miv-711, a Novel Cathepsin K Inhibitor Demonstrates Evidence of Osteoarthritis Structure Modification: Results from a 6 Month Randomized Double-Blind Placebo-Controlled Phase IIA Trial. ACR 2017, abstract 14L.
Cardiovasculaire risicofactoren bij primair syndroom van Sjögren
jan 2024 | Ritmestoornissen, Sjögren